How is diabetic maculopathy diagnosed?

Diabetic maculopathy, a complication of diabetes affecting the macula in the eye, is a leading cause of vision impairment among diabetic patients. Early diagnosis is crucial for preventing long-term damage and preserving sight. Understanding the diagnostic process can help patients seek timely and effective care.

What are the initial steps in diagnosing diabetic maculopathy?

The diagnostic process usually begins during a routine diabetic eye screening or an ophthalmology consultation. Patients with diabetes are encouraged to attend annual screenings to monitor for diabetic retinopathy and maculopathy, as early detection plays a significant role in managing these conditions.

Medical history and symptoms: The specialist will review the patient's medical history and ask about any symptoms such as blurred vision, difficulty focusing, or sensitivity to light.

Visual acuity test: This test measures how well the patient can see at various distances, identifying any changes in central vision that may indicate macular involvement.

What imaging techniques are used to diagnose diabetic maculopathy?

Advanced imaging techniques are key to confirming a diagnosis of diabetic maculopathy and determining its severity.

Fundus photography: High-resolution images of the retina are taken to identify changes such as swelling, bleeding, or fatty deposits near the macula.

Optical coherence tomography (OCT): This non-invasive scan provides detailed cross-sectional images of the retina, allowing the ophthalmologist to assess the thickness of the macula and detect fluid accumulation or structural abnormalities.

Fluorescein angiography: In some cases, a dye is injected into the patient’s bloodstream, and specialised images are taken to examine the blood vessels in the retina. This test helps identify areas of leakage or abnormal blood vessel growth contributing to macular damage.

Who should be screened for diabetic maculopathy?

Individuals with diabetes, particularly those with poor blood sugar control or long-standing diabetes, are at a higher risk of developing maculopathy. Regular screening is essential, as early stages of diabetic maculopathy may not present noticeable symptoms.

By attending regular screenings and undergoing appropriate imaging tests, diabetic maculopathy can be diagnosed promptly, allowing for timely interventions to prevent vision loss.

How is diabetic maculopathy treated?

Treatment for diabetic maculopathy focuses on reducing macular swelling and preventing further vision loss. The specific approach depends on the severity of the condition and the patient's overall health.

Intravitreal injections, such as anti-vascular endothelial growth factor (anti-VEGF) drugs, are commonly used to reduce swelling and prevent abnormal blood vessel growth.

Laser photocoagulation may also be employed to seal leaking blood vessels in the retina.

In more advanced cases, where the macula is significantly affected or there are complications such as vitreous haemorrhage, vitreoretinal surgery may be necessary. This surgery involves removing the gel-like vitreous inside the eye and replacing it to stabilise the retina and improve vision.

Early diagnosis and timely treatment are crucial to achieving the best outcomes and preserving sight.